The Cigna Group (CI) — financial distillation
Annual history (10-K)
Quarterly history (10-Q)
Two headline lines are shown to start. Click any item in a legend to add or remove it — every figure on the chart is one the table below also carries, for the period it names.
In brief, from the full filed history
- Revenue grew from $39.84B (period ending 2016-12-31) to $274.90B (period ending 2025-12-31) — a 23.9% annual pace across 9 year(s) of filed history.
- Net margin held close to 2.2% over that same span.
- Across 26 tracked quarters, the strongest was $71.67B (quarter ending 2026-06-30) and the weakest was $11.41B (quarter ending 2018-03-31).
Annual — most recent 10-K
| Line | Value | Period ends | Form | Filing |
|---|---|---|---|---|
| Revenue | $274.90B | 2025-12-31 | 10-K | 0001739940-26-000006 |
| Operating income | $9.20B | 2025-12-31 | 10-K | 0001739940-26-000006 |
| Net income | $5.96B | 2025-12-31 | 10-K | 0001739940-26-000006 |
| Diluted EPS | $22.18 | 2025-12-31 | 10-K | 0001739940-26-000006 |
| Total assets | $157.92B | 2025-12-31 | 10-K | 0001739940-26-000006 |
| Total liabilities | $116.05B | 2025-12-31 | 10-K | 0001739940-26-000006 |
| Cash & equivalents | $7.68B | 2025-12-31 | 10-K | 0001739940-26-000006 |
| Operating cash flow | $9.60B | 2025-12-31 | 10-K | 0001739940-26-000006 |
Quarterly — most recent 10-Q
| Line | Value | Period ends | Form | Filing |
|---|---|---|---|---|
| Revenue | $71.67B | 2026-06-30 | 10-Q | 0001739940-26-000065 |
| Operating income | $2.68B | 2026-06-30 | 10-Q | 0001739940-26-000065 |
| Net income | $1.66B | 2026-06-30 | 10-Q | 0001739940-26-000065 |
| Diluted EPS | $6.29 | 2026-06-30 | 10-Q | 0001739940-26-000065 |
| Total assets | $157.08B | 2026-06-30 | 10-Q | 0001739940-26-000065 |
| Total liabilities | $114.17B | 2026-06-30 | 10-Q | 0001739940-26-000065 |
| Cash & equivalents | $6.30B | 2026-06-30 | 10-Q | 0001739940-26-000065 |
| Operating cash flow | $1.13B | 2026-03-31 | 10-Q | 0001739940-26-000043 |
Reading
The figures above are taken directly from filings with the U.S. Securities and Exchange Commission. The reading below was generated by a local language model from only those figures; it introduces no numbers of its own. It is not investment advice.
The Cigna Group, as reflected in its SEC filings, operates on a substantial scale, with revenues surging from $39.84 billion in 2016 to $274.90 billion in 2025, demonstrating an impressive 23.9% annual growth rate over nine years. This rapid expansion underscores the company’s significant market presence and robust business performance. The multi-year revenue trajectory reveals a consistent upward trend, indicating sustained growth.
Net income has also shown resilience, maintaining an average margin of approximately 2.2% throughout this period. Despite fluctuations, the company managed to report net incomes ranging from $3.43 billion in 2024 to $5.96 billion in 2025. The most recent quarterly revenue of $71.67 billion signifies continued strength, although it’s noteworthy that this figure is lower than the peak annual revenue but higher than any recorded quarterly revenue to date.
In upcoming filings, investors should monitor Cigna’s ability to sustain its growth momentum amidst potential market saturation or regulatory changes. Additionally, scrutiny of operating income trends will be crucial, given the company’s substantial liabilities and the need for efficient cash flow management, as evidenced by fluctuations between robust quarterly figures like $1.13 billion and annual operating cash flows such as $9.60 billion in 2025.
Source: SEC EDGAR company facts for CIK 0001739940 · filings index